{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T15:46:30Z","timestamp":1794584790827,"version":"4.9.1"},"reference-count":68,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Tuberculosis (TB) persists as a formidable global health challenge, particularly due to the emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) variants that limit the effectiveness of existing therapies. These variants limit therapeutic options, prolong treatment duration and increase the risk of treatment failure. Additionally, the antitubercular drug discovery remains relatively limited; moreover, the rise in drug-resistant strains necessitates the need to identify and develop novel drug candidates that can overcome these resistance patterns. This study aims to design novel InhA inhibitors that can bind to and inhibit InhA and circumvent the resistance pathway in the KatG enzyme of Mycobacterium tuberculosis. We sourced an extensive library of 276 518 natural products from the LOTUS database and screened the compounds through a series of rigorous computational approaches such as drug-likeness filtration, molecular docking, MM-GBSA analysis, and ADMET prediction. We developed a machine learning model using a Message Passing Neural Network (MPNN). The MPNN was trained to predict bioactivity profiles of 31 597 natural products against the InhA enzyme. Molecular dynamics simulations further confirmed the stability of these interactions over 100-nanoseconds. Out of the screened compounds, four novel drug candidates exhibited strong binding affinities with binding energies of \u221212.204\u202fkcal\/mol, \u221211.926\u202fkcal\/mol, \u221211.624\u202fkcal\/mol, and \u221211.548\u202fkcal\/mol, respectively, surpassing the co-crystallized ligand (\u22128.895\u2009kcal\/mol), and the standard drug, Isoniazid (\u221212.204\u202fkcal\/mol). The top hit molecules demonstrated high and considerable structural stability during molecular dynamics simulations. Additionally, the pharmacokinetic profile of LTS0161715 exhibited low toxicity. positioning LTS0161715 for further investigation. These research findings elucidate the potential of direct InhA inhibitors, particularly LTS0161715, as a promising drug candidate for anti-tubercular drug development, while also highlighting the need for further optimization to enhance safety and efficacy.<\/jats:p>","DOI":"10.1093\/biomethods\/bpag015","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T12:46:44Z","timestamp":1774702004000},"source":"Crossref","is-referenced-by-count":1,"title":["Discovery of novel InhA inhibitors through structural bioinformatics and machine learning-driven QSAR screening of natural products"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3093-3309","authenticated-orcid":false,"given":"Godswill Imolele","family":"Anthony","sequence":"first","affiliation":[{"name":"Department of Genome and Molecular Science, Helix Biogen Institute , Ogbomosho, Sabo Abogunde Road , Ibadan, Oyo, 210212,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Nzube","family":"Nwosu","sequence":"additional","affiliation":[{"name":"Department of Industrial Chemistry, Chukwuemeka Odumegwu University , PMB 02 Uli , Uli, Anambra State, 431106,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adedoyin John-Joy","family":"Owolade","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Obafemi Awolowo University , P.M.M 13 , Ile-Ife, Osun State, 220282,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Temitope Olubanjo","family":"Kehinde","sequence":"additional","affiliation":[{"name":"Deparment of Industrial and Systems Engineering, The Hong Kong Polytechnic University , Hung Hom, Room EF625, 6\/F, Core F, Main Campus, 11 Yuk Choi Road , Hung Hom, Hong Kong, 999077,","place":["Hong Kong"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard Gamah","family":"Teye","sequence":"additional","affiliation":[{"name":"Department of Computer Science, Valley View University , P.O Box DT 595, Adenta , Accra, Ghana, 00233,","place":["Ghana"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Eneojo","family":"Akor","sequence":"additional","affiliation":[{"name":"Chester Medical School, Faculty of Medicine and Life Sciences, University of Chester , Bache Hall, Countess Way , Chester, Cheshire, CH2 1BR,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Favour Segun","family":"Fabuyi","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Federal University of Technology , P.M.B. 704 , Akure, Ondo, 340252,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifeoma Roseline","family":"Nwafor","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, University of Benin , P.M.B 1154 , Benin City, Edo State, 300213,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Precious Kelechi","family":"Oleh","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Covenant University , Km 10, Idiroko Road, Canaanland, P.M.B 1023 , Ota, Ogun State, 112233,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toluwalope Daniel","family":"Ilori","sequence":"additional","affiliation":[{"name":"Faculty of Science, Department of Chemistry, Federal University of Agriculture , P.M.B 2240 , Abeokuta, Ogun State, 110111,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3440-8015","authenticated-orcid":false,"given":"Damilola Samuel","family":"Bodun","sequence":"additional","affiliation":[{"name":"Bioinformatics Research (CUBRE), Covenant University , Km 10, Idiroko Road, Canaanland, P.M.B 1023 , Ota, Ogun State, 112233,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"2026102103480244500_bpag015-B1","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1186\/s12879-025-11439-8","article-title":"Prevalence and contributing factors of drug-resistant tuberculosis (DR-TB) in Iran: a systematic review","volume":"25","author":"Daneshi","year":"2025","journal-title":"BMC Infect Dis"},{"key":"2026102103480244500_bpag015-B2","doi-asserted-by":"publisher","first-page":"100510","DOI":"10.1016\/j.jctube.2025.100510","article-title":"The persistent threat of tuberculosis \u2212 Why ending TB remains elusive?","volume":"38","author":"Suvvari","year":"2025","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"2026102103480244500_bpag015-B3","author":"World Health Organization","year":"2023"},{"key":"2026102103480244500_bpag015-B4","author":"World Health Organization","year":"2021"},{"key":"2026102103480244500_bpag015-B5","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s40249-024-01227-y","article-title":"Global, regional, and national burden of HIV-negative tuberculosis, 1990\u20132021: findings from the Global Burden of Disease Study 2021","volume":"13","author":"Zhang","year":"2024","journal-title":"Infect Dis Poverty"},{"key":"2026102103480244500_bpag015-B6","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4046\/trd.2022.0148","article-title":"Improving tuberculosis medication adherence: the potential of integrating digital technology and health belief model","volume":"86","author":"Sazali","year":"2023","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"2026102103480244500_bpag015-B7","doi-asserted-by":"publisher","first-page":"378","DOI":"10.34297\/ajbsr.2020.07.001181","article-title":"Mechanism of drug resistance in Mycobacterium Tuberculosis","volume":"7","author":"Ayanwale","year":"2020","journal-title":"Am J Biomed Sci Res"},{"key":"2026102103480244500_bpag015-B8","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1007\/s00204-016-1727-6","article-title":"Antibiotic resistance mechanisms in M. tuberculosis: an update","volume":"90","author":"Nguyen","year":"2016","journal-title":"Arch Toxicol"},{"key":"2026102103480244500_bpag015-B9","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3390\/antibiotics3030317","article-title":"Drug resistance mechanisms in Mycobacterium tuberculosis","volume":"3","author":"Palomino","year":"2014","journal-title":"Antibiotics (Basel)"},{"key":"2026102103480244500_bpag015-B10","doi-asserted-by":"publisher","first-page":"107515","DOI":"10.1016\/j.micpath.2025.107515","article-title":"Recent advances in inhibitor development and metabolic targeting in tuberculosis therapy","volume":"203","author":"Patel","year":"2025","journal-title":"Microb Pathog"},{"key":"2026102103480244500_bpag015-B11","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/cmdc.201600020","article-title":"N-Benzyl-4-((heteroaryl)methyl)benzamides: a new class of direct NADH-dependent 2-trans enoyl-acyl carrier protein reductase (InhA) inhibitors with antitubercular activity","volume":"11","author":"Guardia","year":"2016","journal-title":"ChemMedChem"},{"key":"2026102103480244500_bpag015-B12","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ejmech.2015.10.008","article-title":"Structure activity relationships of 4-hydroxy-2-pyridones: a novel class of antituberculosis agents","volume":"106","author":"Ng","year":"2015","journal-title":"Eur J Med Chem"},{"key":"2026102103480244500_bpag015-B13","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2478\/acph-2025-0016","article-title":"Development and evaluation of novel InhA inhibitors inspired by thiadiazole and tetrahydropyran series of inhibitors","volume":"75","author":"Rambaher","year":"2025","journal-title":"Acta Pharm"},{"key":"2026102103480244500_bpag015-B14","doi-asserted-by":"publisher","first-page":"869","DOI":"10.2217\/fmb-2019-0085","article-title":"Novel isoniazid derivative as promising antituberculosis agent","volume":"15","author":"Volynets","year":"2020","journal-title":"Future Microbiol"},{"key":"2026102103480244500_bpag015-B15","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.2174\/1381612819666131118203641","article-title":"New approaches to target the mycolic acid biosynthesis pathway for the development of tuberculosis therapeutics","volume":"20","author":"North","year":"2014","journal-title":"Curr Pharm Des"},{"key":"2026102103480244500_bpag015-B16","doi-asserted-by":"publisher","first-page":"107250","DOI":"10.1016\/j.bioorg.2024.107250","article-title":"Unlocking InhA: novel approaches to inhibit Mycobacterium tuberculosis","volume":"146","author":"Wahan","year":"2024","journal-title":"Bioorg Chem"},{"key":"2026102103480244500_bpag015-B17","doi-asserted-by":"publisher","first-page":"100085","DOI":"10.1016\/j.amolm.2025.100085","article-title":"Identification and exploration of novel FGFR-1 inhibitors in the Lotus database for Cholangiocarcinoma (CCA) treatment","volume":"5","author":"Osunnaya","year":"2025","journal-title":"Asp Mol Med"},{"key":"2026102103480244500_bpag015-B18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13321-017-0232-0","article-title":"Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set","volume":"9","author":"Lenselink","year":"2017","journal-title":"J Cheminform"},{"key":"2026102103480244500_bpag015-B19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.37532\/jmoc.2023.6(4).115-118","article-title":"Molecular docking: navigating the realm of drug discovery at the atomic level","volume":"6","author":"James","year":"2023","journal-title":"J Med Org Chem"},{"key":"2026102103480244500_bpag015-B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s44371-025-00209-9","article-title":"HPLC characterization, molecular docking, QSAR and molecular dynamics simulation of Alstonia boonei phytochemical analogs as potent 5-alpha reductase inhibitors","volume":"2","author":"Oluyele","year":"2025","journal-title":"Discov Chem"},{"key":"2026102103480244500_bpag015-B21","doi-asserted-by":"publisher","first-page":"100359","DOI":"10.1016\/j.microb.2025.100359","article-title":"Computational design of novel diphtheria toxin inhibitors using natural products-based drug discovery","volume":"7","author":"Owolade","year":"2025","journal-title":"Microbe"},{"key":"2026102103480244500_bpag015-B22","doi-asserted-by":"publisher","first-page":"100092","DOI":"10.1016\/j.amolm.2025.100092","article-title":"In silico identification of potential HDAC3 inhibitors through machine learning, molecular docking, and molecular dynamics simulations for drug repurposing","volume":"6","author":"Dosunmu","year":"2025","journal-title":"Asp Mol Med"},{"key":"2026102103480244500_bpag015-B23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.compbiolchem.2018.02.008","article-title":"Multiple grid arrangement improves ligand docking with unknown binding sites: application to the inverse docking problem","volume":"73","author":"Ban","year":"2018","journal-title":"Comput Biol Chem"},{"key":"2026102103480244500_bpag015-B24","doi-asserted-by":"publisher","first-page":"107238","DOI":"10.1016\/j.bioorg.2024.107238","article-title":"Identification of phytochemicals with inhibitory potential against beta-lactamase enzymes via computer aided approach","volume":"145","author":"Nwokebu","year":"2024","journal-title":"Bioorg Chem"},{"key":"2026102103480244500_bpag015-B25","doi-asserted-by":"publisher","first-page":"100182","DOI":"10.1016\/j.insi.2026.100182","article-title":"Integrative machine learning and structural bioinformatics strategies for the identification of selective sterol 14A-demethylase inhibitors targeting Trypanosoma Cruzi","volume":"2","author":"Omoseeye","year":"2026","journal-title":"In Silico Research in Biomedicine"},{"key":"2026102103480244500_bpag015-B26","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin Drug Discov"},{"key":"2026102103480244500_bpag015-B27","doi-asserted-by":"publisher","first-page":"101065","DOI":"10.1016\/j.imu.2022.101065","article-title":"A molecular modeling approach for structure-based virtual screening and identification of novel anti-hypercholesterolemic agents from Grape","volume":"32","author":"Akinnusi","year":"2022","journal-title":"Inform Med Unlocked"},{"key":"2026102103480244500_bpag015-B28","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci Rep"},{"key":"2026102103480244500_bpag015-B29","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-94651-7_7","article-title":"Molecular dynamics simulations: concept, methods, and applications","author":"Badar","journal-title":"Transdisciplinarity"},{"key":"2026102103480244500_bpag015-B30","doi-asserted-by":"publisher","first-page":"129852","DOI":"10.1016\/j.bmcl.2024.129852","article-title":"Machine learning-based QSAR and LB-PaCS-MD guided design of SARS-CoV-2 main protease inhibitors","volume":"110","author":"Toopradab","year":"2024","journal-title":"Bioorg Med Chem Lett"},{"key":"2026102103480244500_bpag015-B31","doi-asserted-by":"publisher","first-page":"e201800025","DOI":"10.26508\/lsa.201800025","article-title":"Discovery of a cofactor-independent inhibitor of Mycobacterium tuberculosis InhA","volume":"1","author":"Xia","year":"2018","journal-title":"Life Sci Alliance"},{"key":"2026102103480244500_bpag015-B32","doi-asserted-by":"publisher","first-page":"269ra3","DOI":"10.1126\/scitranslmed.3010597","article-title":"Direct inhibitors of InhA are active against Mycobacterium tuberculosis","volume":"7","author":"Manjunatha","year":"2015","journal-title":"Sci Transl Med"},{"key":"2026102103480244500_bpag015-B33","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.drudis.2016.09.009","article-title":"This review provides insight into the most advanced InhA inhibitors, which show clear evidence of successful target engagement and represent excellent pointers for further drug optimization. A new \u201cgolden age\u201d for the antitubercular target InhA","volume":"22","author":"Ro\u017eman","year":"2017","journal-title":"Drug Discov Today"},{"key":"2026102103480244500_bpag015-B34","doi-asserted-by":"publisher","DOI":"10.1128\/mSystems.00113-19","article-title":"Natural products and synthetic biology: where we are and where we need to go","volume":"4","author":"Kunakom","year":"2019","journal-title":"MSystems"},{"key":"2026102103480244500_bpag015-B35","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nchem.1243","article-title":"Quantifying the chemical beauty of drugs","volume":"4","author":"Bickerton","year":"2012","journal-title":"Nat Chem"},{"key":"2026102103480244500_bpag015-B36","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s10858-020-00327-9","article-title":"NMR quality control of fragment libraries for screening","volume":"74","author":"Sreeramulu","year":"2020","journal-title":"J Biomol NMR"},{"key":"2026102103480244500_bpag015-B37","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1758-2946-1-8","article-title":"Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions","volume":"1","author":"Ertl","year":"2009","journal-title":"J Cheminform"},{"key":"2026102103480244500_bpag015-B38","doi-asserted-by":"publisher","first-page":"681","DOI":"10.2174\/1389557043403765","article-title":"Predicting synthetic accessibility: application in drug discovery and development","volume":"4","author":"Baber","year":"2004","journal-title":"Mini Rev Med Chem"},{"key":"2026102103480244500_bpag015-B39","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1021\/acsmedchemlett.9b00314","article-title":"Virtual screening for ligand discovery at the \u03c31 receptor","volume":"11","author":"Greenfield","year":"2020","journal-title":"ACS Med Chem Lett"},{"key":"2026102103480244500_bpag015-B40","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1007\/s11030-020-10151-w","article-title":"Molecular docking studies, molecular dynamics and ADME\/tox reveal therapeutic potentials of STOCK1N-69160 against papain-like protease of SARS-CoV-2","volume":"25","author":"Elekofehinti","year":"2021","journal-title":"Mol Divers"},{"key":"2026102103480244500_bpag015-B41","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202401315","article-title":"Evaluation of phytochemicals for anti-tubercular potential targeting enoyl-acyl carrier protein reductase (InhA): an in silico approach","volume":"9","author":"Gupta","year":"2024","journal-title":"ChemistrySelect"},{"key":"2026102103480244500_bpag015-B42","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.3390\/antibiotics11081038","article-title":"Identification of novel inhibitor of enoyl-acyl carrier protein reductase (InhA) enzyme in mycobacterium tuberculosis from plant-derived metabolites: an In Silico Study","volume":"11","author":"Singh","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"2026102103480244500_bpag015-B43","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1021\/ci6004299","article-title":"Validation studies of the site-directed docking program LibDock","volume":"47","author":"Rao","year":"2007","journal-title":"J Chem Inf Model"},{"key":"2026102103480244500_bpag015-B44","doi-asserted-by":"publisher","first-page":"13398","DOI":"10.1038\/s41598-023-40160-2","article-title":"Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management","volume":"13","author":"Agu","year":"2023","journal-title":"Sci Rep"},{"key":"2026102103480244500_bpag015-B45","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.3390\/ijms20184331","article-title":"Molecular docking: shifting paradigms in drug discovery","volume":"20","author":"Pinzi","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2026102103480244500_bpag015-B46","doi-asserted-by":"publisher","first-page":"0098","DOI":"10.34133\/hds.0098","article-title":"Current trends and challenges in drug-likeness prediction: are they generalizable and interpretable?","volume":"3","author":"Zhu","year":"2023","journal-title":"Health Data Sci"},{"key":"2026102103480244500_bpag015-B47","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.addr.2015.01.009","article-title":"The application of in silico drug-likeness predictions in pharmaceutical research","volume":"86","author":"Tian","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"2026102103480244500_bpag015-B48","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/s0169-409x(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv Drug Deliv Rev"},{"key":"2026102103480244500_bpag015-B49","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.addr.2016.05.007","article-title":"BDDCS, the Rule of 5 and drugability","volume":"101","author":"Benet","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"2026102103480244500_bpag015-B50","doi-asserted-by":"publisher","first-page":"171","DOI":"10.46793\/chemn3.1.171i","article-title":"Lipinski\u2019s rule of five, famous extensions and famous exceptions","volume":"3","author":"Ivanovi\u0107","year":"2020","journal-title":"Chemia Naissensis"},{"key":"2026102103480244500_bpag015-B51","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1002\/jcc.27086","article-title":"Development and test of highly accurate endpoint free energy methods. 2: prediction of logarithm of n-octanol\u2013water partition coefficient (logP) for druglike molecules using MM-PBSA method","volume":"44","author":"Sun","year":"2023","journal-title":"J Comput Chem"},{"key":"2026102103480244500_bpag015-B52","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1517\/17460441.2012.714363","article-title":"The influence of lipophilicity in drug discovery and design","volume":"7","author":"Arnott","year":"2012","journal-title":"Expert Opin Drug Discov"},{"key":"2026102103480244500_bpag015-B53","author":"Velmourougane","year":"2022"},{"key":"2026102103480244500_bpag015-B54","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1039\/D0RA09995C","article-title":"The importance of intramolecular hydrogen bonds on the translocation of the small drug piracetam through a lipid bilayer","volume":"11","author":"Coimbra","year":"2021","journal-title":"RSC Adv"},{"key":"2026102103480244500_bpag015-B55","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1039\/c1md00093d","article-title":"Intramolecular hydrogen bonding to improve membrane permeability and absorption in beyond rule of five chemical space","volume":"2","author":"Alex","year":"2011","journal-title":"Med Chem Commun"},{"key":"2026102103480244500_bpag015-B56","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13321-025-00947-z","article-title":"ADMET evaluation in drug discovery: 21. Application and industrial validation of machine learning algorithms for Caco-2 permeability prediction","volume":"17","author":"Wang","year":"2025","journal-title":"J Cheminform"},{"key":"2026102103480244500_bpag015-B57","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.3390\/pharmaceutics15112523","article-title":"Caco-2 cell line standardization with pharmaceutical requirements and in vitro model suitability for permeability assays","volume":"15","author":"Kus","year":"2023","journal-title":"Pharmaceutics (Basel)"},{"key":"2026102103480244500_bpag015-B58","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.xphs.2020.09.017","article-title":"P-glycoprotein substrate assessment in drug discovery: application of modeling to bridge differential protein expression across in vitro tools","volume":"110","author":"Li","year":"2021","journal-title":"J Pharm Sci"},{"key":"2026102103480244500_bpag015-B59","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1080\/13543776.2025.2470294","article-title":"A patent review of CYP3A4 inhibitors (2018 \u2013 present)","volume":"35","author":"Tu","year":"2025","journal-title":"Expert Opin Ther Pat"},{"key":"2026102103480244500_bpag015-B60","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s44371-025-00130-1","article-title":"Protein\u2013ligand molecular dynamics simulation (PL-MDS), ADMET analyses, and bioactivity studies of phytochemicals from Aloe Vera: an In-Silico novel antidiabetics drug discovery effort","volume":"2","author":"Ogunyemi","year":"2025","journal-title":"Discov Chem"},{"key":"2026102103480244500_bpag015-B61","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s10822-025-00624-1","article-title":"Machine learning-based QSAR and structure-based virtual screening guided discovery of novel mIDH1 inhibitors from natural products","volume":"39","author":"Bai","year":"2025","journal-title":"J Comput Aided Mol Des"},{"key":"2026102103480244500_bpag015-B62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07391102.2020.1815584","article-title":"Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of natural compounds against the SARS-CoV-2 main-protease","volume":"40","author":"Shivanika","year":"2020","journal-title":"J Biomol Struct Dyn"},{"key":"2026102103480244500_bpag015-B63","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1080\/07391102.2021.2009914","article-title":"Hibiscus sabdariffa anthocyanins are potential modulators of estrogen receptor alpha activity with favourable toxicology: a computational analysis using molecular docking, ADME\/Tox prediction, 2D\/3D QSAR and molecular dynamics simulation","volume":"41","author":"Laskar","year":"2023","journal-title":"J Biomol Struct Dyn"},{"key":"2026102103480244500_bpag015-B64","doi-asserted-by":"publisher","first-page":"103753","DOI":"10.1016\/j.sjbs.2023.103753","article-title":"Molecular dynamics and simulation analysis against superoxide dismutase (SOD) target of micrococcus luteus with secondary metabolites from Bacillus licheniformis recognized by genome mining approach","volume":"30","author":"Bagewadi","year":"2023","journal-title":"Saudi J Biol Sci"},{"key":"2026102103480244500_bpag015-B65","doi-asserted-by":"publisher","first-page":"8722","DOI":"10.1021\/jp302103t","article-title":"Comparison of multiscale methods for the analysis of molecular dynamics simulations","volume":"116","author":"Benson","year":"2012","journal-title":"J Phys Chem B"},{"key":"2026102103480244500_bpag015-B66","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1080\/07391102.2016.1165736","article-title":"Deciphering the mechanism behind the varied binding activities of COXIBs through molecular dynamic simulations, MM-PBSA binding energy calculations and per-residue energy decomposition studies","volume":"35","author":"Chaudhary","year":"2017","journal-title":"J Biomol Struct Dyn"},{"key":"2026102103480244500_bpag015-B67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/1178228","article-title":"Molecular dynamics simulation of ligands from Anredera cordifolia (Binahong) to the main protease (Mpro) of SARS-CoV-2","volume":"2022","author":"Fatriansyah","year":"2022","journal-title":"J Trop Med"},{"key":"2026102103480244500_bpag015-B68","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1080\/07391102.2020.1771424","article-title":"Fragment tailoring strategy to design novel chemical entities as potential binders of novel corona virus main protease","volume":"39","author":"Choudhury","year":"2021","journal-title":"J Biomol Struct Dyn"}],"container-title":["Biology Methods and Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/biomethods\/advance-article-pdf\/doi\/10.1093\/biomethods\/bpag015\/67664598\/bpag015.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biomethods\/article-pdf\/11\/1\/bpag015\/67664598\/bpag015.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biomethods\/article-pdf\/11\/1\/bpag015\/67664598\/bpag015.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T07:48:10Z","timestamp":1792568890000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biomethods\/article\/doi\/10.1093\/biomethods\/bpag015\/8561080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,12]]}},"URL":"https:\/\/doi.org\/10.1093\/biomethods\/bpag015","relation":{},"ISSN":["2396-8923"],"issn-type":[{"value":"2396-8923","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2026]]},"article-number":"bpag015"}}